Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the ...

Am J Geriatr Cardiol. 2005;14(1):35-38. A second large (N=2010) trial, Mode Selection Trial (MOST), [15] was published in 2002. This study was restricted to patients with SSS. No difference was seen ...

PHILADELPHIA — Accelerometer-based atrial sensing with a novel, enhanced, automated algorithm in patients with atrioventricular block and a single-chamber leadless pacemaker in the right ventricle ...

(HealthDay)—Intrabody, wireless unidirectional communication is possible using a leadless cardiac pacemaker (LCP) and subcutaneous implantable-cardioverter defibrillator (S-ICD), according to a letter ...

Cardiac pacing has undergone a remarkable transformation over the past few decades, from the 1950s to the present era, ...

First results in human patients of a novel leadless pacemaker were presented last week at the HRS meeting in Denver by Vivek Reddy. Pacemaker leads are the most common source of complications ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

Results Presented at ESC 2021 Show Micra TPS Compares Favorably to Traditional Pacemakers DUBLIN, Aug. 27, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today ...

Dual‑chamber pacemakers have pacing leads in the right atrium and ventricle. They are indicated for use in the treatment of atrioventricular block in the absence of continuous atrial fibrillation, and ...

On the negative side and particularly in years past, adding an atrial lead increased the time taken for an implant procedure and made postoperative lead displacement and monitoring challenges more ...